What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?

Journal of Clinical Nursing

Volumn 19, Issue 7-8, 2010, Pages 904-916

  Cary, Virginia A ^a   Boullata, Joseph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CAM; IBD; Inflammatory bowel disease; Nutrition; Probiotics

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM; DAIRY PRODUCT; ENTERITIS; ESCHERICHIA COLI; HUMAN; LACTOBACILLUS; REVIEW; SACCHAROMYCES;

BIFIDOBACTERIUM; CULTURED MILK PRODUCTS; ESCHERICHIA COLI; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS; PROBIOTICS; SACCHAROMYCES;

EID: 77955944234     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2009.03123.x     Document Type: Review

References (23)

1. Baroja LM, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clinical & Experimental Immunology 2007, 149:470-479.
2. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 2005, 100:1539-1546.
3. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clinical Infectious Diseases 2003, 36:775-780.
4. Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Olivia-Hemker M, Rosh JR, Tolia V, Zholuder A, Vanderhoof JA, Hibberd PL. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflammatory Bowel Diseases 2005, 11:833-839.
5. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. Journal of Paediatrics and Child Health 2004, 40:681-684.
6. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflammatory Bowel Diseases 2004, 10:286-299.
7. Gupta P, Haikaeli A, Kirschner B, Guandalini S. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. Journal of Pediatric Gastroenterology and Nutrition 2000, 31:453-457.
8. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Digestive Diseases and Sciences 2000, 45:1462-1464.
9. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of Bifidobacteria-fermented milk on ulcerative colitis. Journal of the American College of Nutrition 2003, 22:56-63.
10. Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany-a survey of patients with inflammatory bowel disease. BMC Complementary and Alternative Medicine 2006, 6:19.
11. Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, Otsuka M, Hasunuma O, Kurihara R, Iwasaki A, Arakawa Y. Randomized placebo-controlled trial assessing the effect of Bifidobacteria-fermented milk on active ulcerative colitis. Alimentary Pharmacology & Therapeutics 2004, 20:1133-1141.
12. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology & Therapeutics 1997, 11:853-858.
13. Kruis W, Fric P, Lucas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J. Maintaining remission of ulcerative colitis with the probiotic Eschericia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53:1617-1623.
14. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Practice & Research in Clinical Gastroenterology 2003, 17:725-740.
15. Marteau P, Lepage P, Mangin I, Suau A, Dore J, Pochart P, Seksik P. Review article: gut flora and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2004, 20:18-23.
16. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. Journal of Pediatric Gastroenterology and Nutrition 2006, 43:550-557.
17. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51:405-409.
18. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Eshcherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. The Lancet 1999, 354:635-639.
19. Sackett DL. Rules of evidence and clinical recommendations on the use of anti-thrombotic agents. Chest 1989, 95:2S-4S.
20. Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterology 2004, 4:1-4.
21. Shanahan F. Probiotics in inflammatory bowel disease. Gut 2001, 48:609.
22. Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Practice & Research in Clinical Gastroenterology 2003, 17:805-820.
23. Van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, Fontaine F, DeVos M, Enslen M, Paintin M, Franchimont D. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileocaecal resection. Inflammatory Bowel Diseases 2006, 13:135-142.